MIDTERM PRIMARY VOTING RESULTS

Recent Quotes
My Watchlist
Indicators
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

267.08 -2.04 (-0.76%)
Official Closing Price Updated: 4:10 PM EDT, Sep 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Johnson & Johnson Eyes High-End MedTech Growth as Cardiovascular Takes Center Stage ↗
Johnson & Johnson (NYSE:JNJ) MedTech Chairman Tim Schmid said the company remains confident it is delivering growth at the high end of its previously stated 5% to 7% operational market-growth range for... 
Via MarketBeat
Topics ETFs Economy
Stay informed with the top movers within the dow jones index on Wednesday. ↗
Via Chartmill
News headline image
2 Dividend Stocks Built to Hold Up When Markets Don't ↗
These two are on the Dividend Kings list. 
Via The Motley Fool
Topics Artificial Intelligence Economy
Stay informed with the top movers within the dow jones index on Tuesday. ↗
Via Chartmill
News headline image
If I Were in My 20s, I'd Buy This Vanguard ETF Warren Buffett Recommended and Hold It Forever ↗
Low-cost index funds can be a ticket to prosperity for everyday investors. 
Via The Motley Fool
Topics ETFs Economy
What's going on in today's session: dow jones movers ↗
Via Chartmill
News headline image
5 Defensive Stocks to Watch as CPI and the Fed Put the Rally to the Test ↗
Ahead of CPI data and the Fed's rate decision, defensive stocks McDonald's, Johnson & Johnson, Walmart, Berkshire Hathaway, and NextEra Energy offer stability and dividends amid market uncertainty. 
Via MarketBeat
Topics Economy
News headline image
If the Fed Hikes Interest Rates This Month, History Says This Is the Smartest ETF to Buy Right Now ↗
If interest rates rise, writing a prescription today for the State Street Health Care Select Sector SPDR ETF is a smart idea. 
Via The Motley Fool
Topics ETFs Economy Regulatory Compliance
News headline image
Intuitive Surgical's Growth Has Cooled From Its Post-Pandemic Highs. Is That a Buying Opportunity or a Warning? ↗
Intuitive Surgical's flywheel isn't selling new surgical robots, its selling parts and services to support the ones it has already sold. 
Via The Motley Fool
News headline image
Johnson & Johnson to Participate in the Deutsche Bank 2026 Healthcare Summit
From Johnson & Johnson
Via Business Wire
Discover which dow jones stocks are making waves on Wednesday. ↗
Via Chartmill
Which dow jones stocks are moving on Wednesday? ↗
Via Chartmill
Stay informed with the top movers within the dow jones index on Tuesday. ↗
Via Chartmill
These dow jones stocks are moving in today's session ↗
Via Chartmill
News headline image
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson Owns Stakes in 15 Stocks. Here's the Best of the Bunch. ↗
One of J&J's investments stands head-and-shoulders above the rest. 
Via The Motley Fool
News headline image
AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? ↗
AbbVie trades cheaper but carries heavy revenue concentration; Johnson & Johnson boasts a fortress balance sheet and wider portfolio. 
Via The Motley Fool
News headline image
Warren Buffett Thinks Investors Are "Gambling" Right Now. Here are 2 Stocks That Should Be Safe Bets. ↗
Johnson & Johnson and Merck are healthcare giants with dependable returns that weather economic downturns well. 
Via The Motley Fool
Topics Economy
News headline image
I Think Johnson & Johnson Is the Best Dividend Stock to Buy Right Now ↗
Looking for a dividend stock you can sleep well owning? Here's why Johnson & Johnson could be the long-term healthcare anchor your portfolio needs. 
Via The Motley Fool
Topics Intellectual Property
Thursday's session: top gainers and losers in the dow jones index ↗
Via Chartmill
Exploring the top movers within the dow jones index during today's session. ↗
Via Chartmill
News headline image
Johnson & Johnson Just Got a Big FDA Win ↗
The company's autoimmune drug was approved for the treatment of a rare blood disease. 
Via The Motley Fool
News headline image
I Think Johnson & Johnson Is the Best Dividend Stock to Buy Right Now ↗
The company is firing on all cylinders. 
Via The Motley Fool
Topics Intellectual Property
Explore the top gainers and losers within the dow jones index in today's session. ↗
Via Chartmill
These dow jones stocks are moving in today's session ↗
Via Chartmill
Top dow jones movers in Tuesday's session ↗
Via Chartmill
News headline image
Johnson & Johnson Secures FDA Approval For First Rare Anemia Treatment ↗
Johnson & Johnson secured FDA approval for IMAAVY, the first targeted therapy to treat warm autoimmune hemolytic anemia in adults and youth. 
Via Benzinga
Exploring the top movers within the dow jones index during today's session. ↗
Via Chartmill
Explore the top gainers and losers within the dow jones index in today's session. ↗
Via Chartmill
News headline image
Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson? ↗
These two high-quality dividend payers have had very different fortunes recently. 
Via The Motley Fool
Topics Lawsuit
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Gift this article